BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8152511)

  • 1. [Clinical relevance of resistance against cytostatic agents in children with leukemia].
    Pieters R; Kaspers GJ; Klumper E; van Wering ER; van der Does-van den Berg A; Veerman AJ
    Ned Tijdschr Geneeskd; 1994 Apr; 138(14):706-12. PubMed ID: 8152511
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of recurrence in children with acute lymphatic leukemia. Current results and various developments].
    Kaspers GJ; Pieters R; Klumper E; de Waal FC; Veerman AJ
    Tijdschr Kindergeneeskd; 1993 Feb; 61(1):1-7. PubMed ID: 8493696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia.
    Kaspers GJ; Wijnands JJ; Hartmann R; Huismans L; Loonen AH; Stackelberg A; Henze G; Pieters R; Hählen K; Van Wering ER; Veerman AJ
    Eur J Cancer; 2005 Jun; 41(9):1300-3. PubMed ID: 15869873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology and drug resistance in childhood lymphoblastic leukemia.
    Adamson PC; Poplack DG; Balis FM
    Hematol Oncol Clin North Am; 1990 Oct; 4(5):871-94. PubMed ID: 2262483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quest for effective agents to combat T-cell acute lymphoblastic leukemia.
    Pui CH
    Eur J Cancer; 2005 Jun; 41(9):1243-5. PubMed ID: 15939259
    [No Abstract]   [Full Text] [Related]  

  • 7. Biology and treatment of acute lymphoblastic leukemia.
    Pieters R; Carroll WL
    Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High-risk acute lymphoblastic leukemia. Results of a diagnostic-therapeutic protocol].
    Castell V; Verdaguer A; Ferris J; Piqueras AI; Fernández JM
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():89-91. PubMed ID: 3214045
    [No Abstract]   [Full Text] [Related]  

  • 9. [High-risk acute lymphoblastic leukemia].
    Martínez Rubio A; Doñoro Mazario M; Sánchez Luna M; Muro Brussi M; Lamamie de Cleirac P; García-Monge Santidrián S
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():66-8. PubMed ID: 3214041
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building better therapy for children with acute lymphoblastic leukemia.
    Carroll WL; Raetz EA
    Cancer Cell; 2005 Apr; 7(4):289-91. PubMed ID: 15837616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of pediatric acute lymphoblastic leukemia.
    Tucci F; Aricò M
    Haematologica; 2008 Aug; 93(8):1124-8. PubMed ID: 18669975
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acute leukemias].
    Díaz Mediavilla J
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():22-7. PubMed ID: 10422447
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
    Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A
    Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug sensitivity of tumor cells in varieties of acute childhood leukemia].
    Shman TV; Belevtsev MV; Buglova SE
    Vopr Onkol; 2005; 51(5):558-62. PubMed ID: 16756010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art.
    Pieters R; Kaspers GJ; Klumper E; Veerman AJ
    Med Pediatr Oncol; 1994; 22(5):299-308. PubMed ID: 8127253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrence of Varicella-zoster virus infection].
    Marczyńska M
    Pol Tyg Lek; 1989 Aug 21-28; 44(34-35):801-2. PubMed ID: 2485895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteonecrosis in children with acute lymphoblastic leukemia: a 10-year study from northern Greece.
    Tragiannidis A; Athanassiadou F; Papageorgiou T; Petsatodis G; Sidi V; Koliouskas D
    Pediatr Blood Cancer; 2007 Oct; 49(5):764. PubMed ID: 17216599
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of Czech children with acute lymphoblastic leukemia: a report of the Czech Working Group for Pediatric Hematology.
    Starý J; Gajdos P; Hrstková H; Blazek B; Slavík Z; Mihál V; Zahálka F; Jabali Y; Vávra V; Kopecná L; Mydlil J; Trka J
    Med Pediatr Oncol; 2002 Aug; 39(2):125-7. PubMed ID: 12116061
    [No Abstract]   [Full Text] [Related]  

  • 20. Have chemosensitizing strategies for multidrug-resistant childhood acute lymphoblastic leukemia come of age?
    Bourquin JP; Bornhauser B
    Expert Rev Hematol; 2010 Aug; 3(4):369-72. PubMed ID: 21083025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.